Article Details

TG Therapeutics surges as focus turns to launch of new multiple sclerosis therapy

Retrieved on: 2022-12-29 17:23:26

Tags for this article:

Click the tags to see associated articles and topics

TG Therapeutics surges as focus turns to launch of new multiple sclerosis therapy. View article details on hiswai:

Excerpt

The CD20-directed antibody branded as Briumvi will be available for adults ... in line with currently available anti-CD20 monoclonal antibodies.

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up